Pfizer

YTD

ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.

CEO

Albert Bourla

CEOAlbert Bourla

Employees

81,000

Employees81,000

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1849

Founded1849

Employees

81,000

Employees81,000

PFE Key Statistics

Market cap

129.22B

Market cap129.22B

Price-Earnings ratio

15.89

Price-Earnings ratio15.89

Dividend yield

7.55%

Dividend yield7.55%

Average volume

48.73M

Average volume48.73M

High today

$22.86

High today$22.86

Low today

$22.23

Low today$22.23

Open price

$22.40

Open price$22.40

Volume

35.01M

Volume35.01M

52 Week high

$31.54

52 Week high$31.54

52 Week low

$20.92

52 Week low$20.92

PFE News

Simply Wall St 11h

Pfizer Collaborates With Guardant Health on Oncology; Declares US$0.43 Dividend

recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its oncology portfolio through advanced liquid biopsy technology...

TipRanks 1d

Pfizer to have two oral presentations featured in ASCO pre-meeting briefing

The company states: “Pfizer (PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical On...

TipRanks 2d

Lexaria provides GLP-1 update following industry developments

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer (PFE) and by Eli...

Analyst ratings

63%

of 24 ratings

Buy

33.3%

Hold

62.5%

Sell

4.2%

More PFE News

Benzinga 3d

Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline

Pfizer Inc PFE is scheduled to release its first quarter 2025 earnings on 29 April. Analysts forecast adjusted earnings of 70 cents per share with sales of $14...